Filing Details
- Accession Number:
- 0001209191-14-041208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-13 13:39:20
- Reporting Period:
- 2014-06-11
- Filing Date:
- 2014-06-13
- Accepted Time:
- 2014-06-13 12:39:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033150 | N John Kapoor | 444 South Ellis Street Chandler AZ 85224 | Yes | No | Yes | No | |
1575551 | 1989 20 September Dated Trust Kapoor N John | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-11 | 20,000 | $24.54 | 21,144,805 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,991 | Direct | |
Common Stock | 28,144 | Indirect | By Partnership |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.45 to $24.65,inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- By The John N. Kapoor Trust dated September 20, 1989.
- By EJ Financial/NEO Management, L.P. of which the reporting person is Managing General Partner.